Conference on Clinical Research for Rare Diseases

Posted

Date: Tuesday, September 21, 2010

Location: Bethesda, MD

The Rare Diseases Clinical Research Network and the Clinical and Translational Science Awards Program are pleased to announce a one-day conference focused on conducting clinical research in rare diseases. Speakers include expert Clinical Investigators who represent a spectrum of medical diseases and disciplines and are actively engaged in rare disease research, as well as members of the NIH and Industry. The final session will be a dinner meeting with a keynote address given by John Crowley, Former CEO of Novazyme Pharmaceuticals, Inc.; President and CEO of Amicus Therapeutics, Inc.

For full program details, registration material, and travel award application please visit the conference website.